Chapters (42)
“Perhaps she will,” I say, my hand curling around the cell phone in my pocket. I haven’t said anything to my friends, and I probably won’t until later—much later—but I cannot help thinking of the review board that just granted approval for a clinical trial involving a new technology aimed at the neurons affected by AAROD. Given the success of Kiravimab against the artiovirus itself, Declan’s company has enjoyed spectacular funding for their latest project. Around the world, other research continues, the brightest minds of humanity engaged in the never-ending quest to end suffering.
It’s early, far too early, to hope.
But this I believe: someday, Georgia will join us again.